Skip to main content
. 2020 Aug 9;24(5):530–547. doi: 10.1111/1744-9987.13550

TABLE 5.

Medical expenses reimbursed for therapeutic apheresis

Membrane separation method Centrifugal separation method
Transaction DPC/PDPS a Transaction DPC/PDPS a
PE Approx. JPY120 000 b ~218 000 c Fixed amount + JPY42 000 Approx. JPY90 000 b ~188 000 c Fixed fee + JPY42 000
DFPP Approx. JPY108 000 d ~123 000 e Fixed amount + JPY42 000
PA Approx. JPY146 000 f ~159 000 g Fixed amount + JPY42 000
LCAP or GCAP Approx. JPY147 000~150 000 Fixed amount + JPY42 000 Approx. JPY21 000 Fixed fee + JPY42 000
HA (for hepatic coma) Approx. JPY155 000 Fixed amount + JPY42 000
HA (for endotoxin adsorption) Approx. JPY384 000 Fixed amount + JPY42 000

Abbreviations: DFPP, double filtration plasmapheresis; GCAP, granulocyte apheresis; HA, hemoadsorption; PA, plasma adsorption; PE, plasma exchange; LCAP, leukocytapheresis.

a

The amount reimbursed for DPC/PDPS fixed amount comprehensive medical reimbursement has complicated variations depending on the disease, medical activity performed, and hospital coefficient.

b

For plasma exchange using albumin preparation as replacement fluid.

c

For plasma exchange using fresh frozen plasma as replacement fluid.

d

When using 1 × 250 mL 5% albumin preparation and 1 × 50 mL 25% albumin preparation as replacement fluid.

e

When using 1 × 250 mL 5% albumin preparation and 4 × 50 mL 25% albumin preparation as replacement fluid.

f

For plasma component adsorber for fulminant hepatitis.

g

For plasma component adsorbers other than those for fulminant hepatitis (eg, LDL adsorption, immunoadsorption, etc.).